VBK - ETF AI Analysis
Top Page
Vanguard Small-Cap Growth ETF (VBK)
VBK, the Vanguard Small-Cap Growth ETF, has a solid overall rating that reflects a mix of strong growth stories and some more challenging holdings. Top contributors like TechnipFMC, Credo Technology Group, Okta, and nVent Electric support the fund’s quality through robust financial performance, positive earnings call sentiment, and generally favorable technical trends, even though valuations are often on the high side. The main risk factor is that several holdings, such as Revolution Medicines and others with bearish technical signals or profitability issues, add volatility and highlight the fund’s exposure to smaller, growth-focused companies that can be more sensitive to market swings.
VBK vs. SPDR S&P 500 ETF (SPY)
- AUM
- 22.37B
- Region
- North America
- Expense Ratio
- 0.05%
- Beta
- 1.15
- Issuer
- Vanguard
- Inception Date
- Jan 26, 2004
- Dividend Yield
- 0.42%
- Asset Class
- Equity
- Index Tracked
- Morningstar US Small Cap Growth TR USD
VBK Summary
VBK is the Vanguard Small-Cap Growth ETF, which follows the Morningstar US Small Cap Growth Index. It focuses on smaller U.S. companies that are growing quickly, across areas like technology, health care, and industrials. Some well-known holdings include Twilio and Okta. Investors might consider VBK if they want long-term growth and broader diversification beyond large, well-known stocks. However, because it invests in smaller, fast-growing companies, the share price can be more volatile and may go up and down sharply with changes in the market.
How much will it cost me?
VBK has an expense ratio of 0.05%, which means you’ll pay about $0.50 per year for every $1,000 invested. This cost is lower than the average ETF because it’s a passively managed fund that tracks a small-cap growth index rather than paying managers to pick individual stocks.
What would affect this ETF?
VBK could benefit if the U.S. economy stays healthy and innovation-driven, since its focus on small, fast-growing technology and healthcare companies tends to do well when business investment and consumer spending are strong. On the downside, higher interest rates, economic slowdowns, or tighter regulations on tech and healthcare could hurt these smaller, more volatile companies more than larger, established firms, leading to bigger price swings for the ETF.
VBK Top 10 Holdings
VBK is leaning heavily into U.S. small-cap growth, with a clear tilt toward innovative tech and healthcare names. Natera, Illumina, and Okta have been rising and act like the fund’s growth engine, helped by strong momentum and upbeat earnings stories. Pure Storage has also been a steady contributor, adding some tech firepower. On the flip side, Twilio’s mixed recent performance and nVent’s lagging trend have taken a bit of shine off returns. Overall, the ETF is driven by a cluster of fast-moving, domestically focused growth stories.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 NTRA | Natera | 1.62% | $708.93M | $54.62B | 96.05% | 73Outperform |
 TWLO | Twilio | 1.28% | $562.56M | $32.12B | 57.07% | 70Neutral |
 RVMD | Revolution Medicines | 1.19% | $523.45M | $40.33B | 227.37% | 52Neutral |
 ILMN | Illumina | 1.18% | $517.70M | $34.26B | 98.52% | 71Outperform |
 P | Everpure | 1.18% | $517.25M | $37.91B | 19.32% | 64Neutral |
 OKTA | Okta | 1.00% | $437.71M | $32.32B | 108.26% | 75Outperform |
 EME | EMCOR Group | 0.95% | $416.91M | $29.89B | 5.03% | 73Outperform |
 CRDO | Credo Technology Group Holding Ltd | 0.94% | $412.66M | $26.32B | -16.46% | 77Outperform |
 FTI | TechnipFMC | 0.76% | $333.65M | $26.00B | 58.53% | 80Outperform |
 NVT | nVent Electric | 0.74% | $325.02M | $19.99B | 15.04% | 76Outperform |
VBK Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VBK, the sentiment is Negative. The current price of 332.62 is below the 20-day moving average (MA) of 334.17, below the 50-day MA of 339.95, and below the 200-day MA of 335.43, indicating a bearish trend. The MACD of -2.46 indicates Negative momentum. The RSI at 46.71 is Neutral, neither overbought nor oversold. The STOCH value of 41.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for VBK.
VBK Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| VBK | $332.62 | $360.00(8.23% Upside) | $22.37B | 0.05% | 65Neutral |
 IJR | $141.05 | $169.86(20.43% Upside) | $106.45B | 0.06% | 65Neutral |
 VB | $292.34 | $365.95(25.18% Upside) | $79.16B | 0.03% | 66Neutral |
 IWM | $279.79 | $371.22(32.68% Upside) | $75.63B | 0.19% | 63Neutral |
 VBR | $245.00 | $284.30(16.04% Upside) | $37.48B | 0.05% | 67Neutral |
 IWO | $352.27 | $490.18(39.15% Upside) | $13.78B | 0.24% | 62Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| VBK | Vanguard Small-Cap Growth ETF | 332.62 | 32.88 | 10.97% | |
| IJR | iShares Core S&P Small Cap ETF | 141.05 | 24.01 | 20.52% | |
| VB | Vanguard Small-Cap ETF | 292.34 | 41.79 | 16.68% | |
| IWM | iShares Russell 2000 ETF | 279.79 | 37.57 | 15.51% | |
| VBR | Vanguard Small Cap Value ETF | 245.00 | 42.55 | 21.02% | |
| IWO | iShares Russell 2000 Growth ETF | 352.27 | 26.94 | 8.28% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.